Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's disease. Several studies reported associations of dopaminergic genes with the occurrence of adverse events of dopaminergic treatment. However, none of these studies adopted a pathway based approach. The aim of...
Saved in:
Main Authors: | Sara Redenšek (Author), Dušan Flisar (Author), Maja Kojović (Author), Milica Gregorič Kramberger (Author), Dejan Georgiev (Author), Zvezdan Pirtošek (Author), Maja Trošt (Author), Vita Dolžan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson's Disease
by: Boštjan Petrič, et al.
Published: (2023) -
Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson's Disease
by: Tina Levstek, et al.
Published: (2021) -
Non-Dopaminergic Systems in Parkinson's Disease
Published: (2020) -
Parkinson's disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022) -
Editorial: Non-Dopaminergic Systems in Parkinson's Disease
by: Cristina Miguelez, et al.
Published: (2020)